{'fraction_non_alphanumeric': 0.03751233958538993, 'fraction_numerical': 0.005923000987166831, 'mean_word_length': 5.71523178807947, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Necessity to invest in research and development activities to combat the threat of antimicrobial resistance: World Health Organization

Dear Editor, Antimicrobial resistance has emerged as one of the most serious public health challenges across the world, and significant adverse health, financial, and social sequels are anticipated.[1] In fact, despite repeated warnings that antibiotics and other medicines are losing their potency (due to abuse of medicines in human, animals, and agriculture sector), the problem has been ignored by most of the stakeholders.[1] Moreover, untoward effects have been observed even in the fields of maternal and child health, sexual and reproductive health, food‐borne diseases, water and sanitation, and infection prevention and control.[1,2] Further, the time is not far, when millions of people will become susceptible to deaths each year from infectious diseases which can be easily cured (such as pneumonia, gonorrhea, tuberculosis, and diarrhea) in the current date.[1,2]